<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5(4)</volume><submitter>Stetson RC</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Infants in neonatal intensive care units require painful and noxious stimuli as part of their care. Judicious use of analgesic medications, including opioids, is necessary. However, these medications have long- and short-term side effects, including potential neurotoxicity. This quality improvement project's primary aim was to decrease opioid exposure by 33% in the first 14 days of life for infants less than 1,250 g at birth within 12 months.&lt;h4>Methods&lt;/h4>A multidisciplinary care team used &lt;i>Define, Measure, Analyze, Improve, Control&lt;/i> methodology to identify root causes of the quality gap including: (1) inconsistent reporting of objective pain scales; (2) variable provider prescribing patterns; and (3) variable provider bedside assessment of pain. These root caus</pubmed_abstract><journal>Pediatric quality &amp; safety</journal><pagination>e312</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7339154</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Reducing Opioid Exposure in a Level IV Neonatal Intensive Care Unit.</pubmed_title><pmcid>PMC7339154</pmcid><pubmed_authors>Smith BN</pubmed_authors><pubmed_authors>Ferrie LJ</pubmed_authors><pubmed_authors>Schuh AR</pubmed_authors><pubmed_authors>Brumbaugh JE</pubmed_authors><pubmed_authors>Schuning VS</pubmed_authors><pubmed_authors>Stetson RC</pubmed_authors><pubmed_authors>Misgen MA</pubmed_authors><pubmed_authors>Fang JL</pubmed_authors><pubmed_authors>Sanders NL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Reducing Opioid Exposure in a Level IV Neonatal Intensive Care Unit.</name><description>&lt;h4>Introduction&lt;/h4>Infants in neonatal intensive care units require painful and noxious stimuli as part of their care. Judicious use of analgesic medications, including opioids, is necessary. However, these medications have long- and short-term side effects, including potential neurotoxicity. This quality improvement project's primary aim was to decrease opioid exposure by 33% in the first 14 days of life for infants less than 1,250 g at birth within 12 months.&lt;h4>Methods&lt;/h4>A multidisciplinary care team used &lt;i>Define, Measure, Analyze, Improve, Control&lt;/i> methodology to identify root causes of the quality gap including: (1) inconsistent reporting of objective pain scales; (2) variable provider prescribing patterns; and (3) variable provider bedside assessment of pain. These root caus</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul-Aug</publication><modification>2025-04-19T01:00:32.371Z</modification><creation>2025-04-07T11:57:05.429Z</creation></dates><accession>S-EPMC7339154</accession><cross_references><pubmed>32766487</pubmed><doi>10.1097/pq9.0000000000000312</doi></cross_references></HashMap>